Provided by Tiger Trade Technology Pte. Ltd.

Veru Inc.

2.30
+0.03001.32%
Post-market: 2.28-0.0221-0.96%16:56 EDT
Volume:23.98K
Turnover:55.38K
Market Cap:36.92M
PE:-1.93
High:2.34
Open:2.28
Low:2.28
Close:2.27
52wk High:7.40
52wk Low:2.10
Shares:16.05M
Float Shares:14.48M
Volume Ratio:0.36
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1898
EPS(LYR):-1.5517
ROE:-60.25%
ROA:-42.92%
PB:0.99
PE(LYR):-1.48

Loading ...

Veru Inc - FY Net Loss From Cont Ops Decreased to $15.7 Mln or $1.07 per Share

THOMSON REUTERS
·
Dec 17, 2025

Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress

THOMSON REUTERS
·
Dec 17, 2025

Veru Inc - Received FDA Regulatory Clarity for Enobosarm in Combination With Glp-1 Ra

THOMSON REUTERS
·
Dec 17, 2025

Top Wall Street Forecasters Revamp Veru Expectations Ahead Of Q4 Earnings

Benzinga
·
Dec 16, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Dec 15, 2025

Veru Inc. to Announce Fiscal Year 2025 Financial Results

Reuters
·
Dec 10, 2025

Veru to Report Fiscal Year 2025 Financial Results on December 17th

GlobeNewswire
·
Dec 10, 2025

Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop

GlobeNewswire
·
Dec 04, 2025

Veru Inc. unveils pipeline targeting obesity and cardiometabolic disease with novel drug combinations

Reuters
·
Nov 20, 2025

Veru to Present Two Abstracts at ObesityWeek 2025

GlobeNewswire
·
Oct 31, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Fiserv, CMS Energy, Moderna

Reuters
·
Oct 31, 2025

BUZZ-Biopharma firm Veru tumbles on $25 mln stock-and-warrants offering

Reuters
·
Oct 30, 2025

Veru Inc - Proceeds to Fund Enobosarm Phase 2B Study

THOMSON REUTERS
·
Oct 30, 2025

Veru Announces Pricing of $25 Million Public Offering

THOMSON REUTERS
·
Oct 30, 2025

Veru Inc - Combined Offering Price Accompanying Series a Warrant & Accompanying Series B Warrant Is $3.00 per Share

THOMSON REUTERS
·
Oct 30, 2025

Veru announces offering of common stock and warrants, no amount given

TIPRANKS
·
Oct 30, 2025

Press Release: Veru Announces Proposed Public Offering

Dow Jones
·
Oct 30, 2025

Veru Inc. Completes Promising Phase 2 Study on Enobosarm for Weight Management

TIPRANKS
·
Oct 28, 2025

Veru Inc. Unveils New Presentation Highlighting Obesity Drug Pipeline and Muscle Preservation Strategy

Reuters
·
Oct 17, 2025

Trump Excludes Generics From Big Pharma Tariff Plan

Dow Jones
·
Oct 09, 2025